| ID | Sequence | Length | GC content |
|---|---|---|---|
| GAGUGGGGGAGAGAGAGGAGACCAGGACAGCUGCUGAGACCUCUAAGAA… | 1059 nt | 0.5458 | |
| GAGUGGGGGAGAGAGAGGAGACCAGGACAGCUGCUGAGACCUCUAAGAA… | 1020 nt | 0.5490 | |
| GAGUGGGGGAGAGAGAGGAGACCAGGACAGCUGCUGAGACCUCUAAGAA… | 1075 nt | 0.5470 |
This gene is the human homolog of murine plunc, and like the mouse gene, is specifically expressed in the upper airways and nasopharyngeal regions. The encoded antimicrobial protein displays antibacterial activity against Gram-negative bacteria. It is thought to be involved in inflammatory responses to irritants in the upper airways and may also serve as a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer. Multiple transcript variants resulting from alternative splicing in the 3' UTR have been detected, but the full-length nature of only three are known. [provided by RefSeq, Aug 2014]
A study in humans developed an RT-qPCR procedure for discriminating nasal secretion from saliva, where the BPIFA1 was highly expressed in nasal secretion (positive in 7/10 samples) and used with a ∆Cq <10 criterion, achieving 70% sensitivity and 100% specificity for nasal secretion identification [Akutsu et al. DOI:10.3390/diagnostics10080519]. Another human study using RNA-seq identified the BPIFA1 as a candidate nasal mucosa marker, where a newly designed primer set showed no cross-reactions in non-nasal samples and was detected in nasal samples from all tested origins (illness, allergy, spicy food, unknown cause) [Chirnside et al. DOI:10.1016/j.fsigen.2020.102317].